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Introduction
Cannulation of the internal jugular vein (CVC) is a 
procedure commonly performed for long-term therapies 
in haematological patients needing chemotherapy, 
apheresis and life support treatments1-3. In patients with 
effective haemostasis, CVC is usually performed with 
a blind, surface landmark-guided (sternocleidomastoid 
muscle, clavicle, cricoid) technique. The most common 
complications associated with this procedure are bleeding, 
haematoma, arterial puncture and pneumothorax; 
damage to neural structures such as phrenic nerve and 
brachial plexus as well as low compliance and long 
procedural time have been reported less commonly4,5.
Ultrasonography (US)-guided CVC is an important, 
safe and cost-effective imaging-based technique, used 
in different emergency settings for high-risk patients. 
There have been several prospective randomised trials 
suggesting that the use of US is associated with a 
reduction in complication rate and an improved first-
pass success when cannulating the internal jugular vein, 
because US allows direct visualisation of the vein's 
orientation, dimension and relation with surrounding 
structures4-7.
We here report clinical outcomes in a retrospective 
study on urgent US-guided CVC procedures in high-risk 
haematological patients with severe thrombocytopenia 
refractory to platelet infusion. 
Materials and methods
Study design 
This was a retrospective study on the safety of urgent 
CVC insertion procedures in haematological patients with 
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technique that could be potentially dangerous in patients with very low platelet counts. In such 
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Materials and methods. We retrospectively studied the safety of urgent CVC procedures in 
haematological patients including those with severe thrombocytopenia (platelet count <30×109/L). 
From January 1999 to June 2009, 431 CVC insertional procedures in 431 consecutive patients were 
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urgent CVC insertion. Patients were placed in Trendelenburg's position, an 18-gauge needle and 
guide-wire were advanced under real-time US guidance into the last part of the internal jugular vein; 
central venous cannulation of the internal jugular vein was performed using the Seldinger technique 
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Results. All 431 patients studied had haematological disorders: 39 had severe thrombocytopenia, 
refractory to platelet transfusion (group 1), while 392 did not have severe thrombocytopenia (group 
2). The general characteristics of the patients in the two groups differed only for platelet count. The 
average time taken to perform the procedure was 4 minutes. Success rates were 97.4% and 97.9% in 
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low platelet counts admitted to the Haematology Unit of 
our Institution over a period of 10 years.
Study population
All the patients included in the study had an underlying 
haematological disease requiring urgent US-guided 
CVC. Our population was divided into two groups on the 
basis of platelet count: group 1 patients had persistent, 
transfusion-refractory, severe thrombocytopenia with 
a platelet count below 30×109/L and were at high risk 
of post-procedural bleeding whereas group 2 patients 
had a baseline or post-transfusion platelet count above 
30×109/L and were considered at low risk of bleeding. 
The indications for urgent CVC in this study were the 
need to deliver chemotherapy, transfusions, parenteral 
nutrition, plasma-exchange or intensive life-support 
therapy. Operators included one thoracic surgeon and 
one nurse with specific experience in the field.
Patients were included in the analysis only if the 
following information was available: time taken to 
perform the US-guided CVC, first pass success, number 
of needle punctures, and complications. All patients were 
followed-up for at least 1 week after the procedure. At 
follow-up, patients underwent a clinical examination, 
the catheter exit site was dressed and the catheter was 
flushed with a heparinised solution.
Complications
Complications were defined as major or minor and 
early (occurring during or immediately after the US-
guided CVC procedure) or late (occurring within 1 week 
after the procedure).
Early complications included vasovagal hypotension, 
vein puncture, haematomas (minor complications), and 
post-procedural bleeding, pneumothorax, haemothorax 
and puncture of an artery or nerve (major complications). 
Late complications were occlusion/malfunction, 
catheter-related blood stream infections (minor 
complications), and vein thrombosis and pulmonary 
embolism (major complications).
Ultrasound-guided central venous catheterisation
All catheters were placed by one thoracic surgeon 
with experience of more than 50 US-guided CVC and 
landmark cannulation procedures in order to minimise 
the risk of operator-related complications and failures8,9. 
The site of placement of the central venous catheter was 
identified by localisation of the vein and evaluation of 
specific risk factors (emphysema, coagulation disorders, 
and special anatomical conditions) in each patient4,10. 
Following standard aseptic techniques to prepare the 
skin of the anterior and lateral surface of the neck, patients 
were placed in the Trendelenburg position, with the head 
rotated towards the opposite side and local anaesthesia 
was administered. A standard Seldinger technique 
was used for cannulation11 of the internal jugular vein. 
The ultrasound probe used was a "Prisma-Diasonics" 
(Sonotron/Diasonics, Les Ulis, France) instrument, with 
a linear transducer (10 MHz). The longitudinal axis of 
the internal jugular vein and its relationship with other 
anatomical structures were identified with the aid of 
Valsalva manoeuvres, which increase the diameter of the 
veins. Under US-guidance (real-time B mode) an 18-gauge 
needle and a guide-wire (0.36 inches) were introduced, 
minimising damage to the surrounding structures. Entry 
into the vein was confirmed by visualising indentation 
on the anterior wall of the vein followed by blood in the 
syringe and absence of resistance or pain after flushing 
a saline solution. The placement of the guide-wire in 
the internal jugular vein was confirmed by rescanning 
the vein. Double lumen 7 Fr and 11 Fr venous catheters 
were placed for chemotherapy and apheresis, respectively. 
The day after the procedure, a 3-day course of antibiotic 
prophylaxis was started with ceftriaxone at the dose of 
1 g/day. Antithrombotic prophylaxis with low molecular 
weight heparin (2,850 IU anti-Xa in patients ≤70 kg or 
3,800 IU anti-Xa in patients >70 kg) was given for 4 
weeks. Patients with a platelet count <30×109/L 1 hour 
before the procedure received a transfusion of two units 
of platelets obtained from apheresis. Each platelet unit 
administered contained approximately 3.0×1011 platelets.
Informed consent and statistics
All patients included in the study signed informed 
consent before undergoing the procedure. The present 
study was approved by the safety Institutional Review 
Board of "P. Giaccone" University Hospital, Palermo 
(Italy).
Demographic data and clinical features were analysed 
using descriptive methods. All data are expressed as 
means ± standard deviations (SD) or as percentages. 
Differences between the two groups at baseline were 
analysed with Student's t-test and the chi-square test 
with Yates' correction for categorical variables. 
Results
The patients' characteristics and clinical data are 
summarised in Table I. Over a period of 10 years (from 
January 1999 to June 2009), 431 US-guided CVC were 
performed in 431 haematological patients, including 39 
(group 1) with severe thrombocytopenia (<30×109/L) 
who were refractory to platelet transfusions. The median 
platelet count before and after platelet transfusion in 
this group was 15×109/L and 29×109/L, respectively; 
34 patients had acute leukaemia and five had idiopathic 
thrombocytopenia. In the other 392 patients (group 2), 
the median platelet count (at baseline or after platelet 
infusion) was 90×109/L. There were no significant 
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differences between the two groups in terms of gender, 
age, body mass index, haemoglobin levels or white blood 
cell count. 
Outcomes including success rates, number of needle 
passes, time taken to perform the procedure and early 
complications are reported in Table II. The average time 
taken to perform the procedure was 4 minutes in both 
groups. In seven cases, all in group 2, the procedure 
was interrupted (because of vasovagal hypotension in 
5 patients and collapse of central vein in 2 patients). 
The rate of single needle punctures was 100% (39/39) 
in group 1 and 95.9% (376/392) in group 2 (P =0.38). 
The causes of two (or more) needle punctures in group 2 
included collapse of the central vein during introduction 
of the needle. The success rate was 97.4% in group 1 
(38/39) and 97.9% (384/392) in group 2 (P =0.57).
An anatomical variation of the site or orientation of 
the internal jugular vein was found in 4.7% of all cases 
(2 in group 1 and 8 in group 2). 
There were no infections or thrombosis, arterial 
punctures with bleeding or pneumothorax, or other major, 
early or late complications. The minor complication 
rate was 2.6% (1/39) in group 1 (1 haematoma) and 
3.0% (12/392) in group 2 (7 cases of subcutaneous 
haematomas and 5 cases of vasovagal hypotension) 
(P =0.10). There was one post-operative catheter 
dislocation in each group.
Discussion
CVC is needed for long-term intravenous therapy in 
patients with haematological disorders. A challenging 
clinical scenario can occur when urgent treatment is 
necessary in patients at high risk of bleeding because 
of an underlying haematological disorder with a very 
low platelet count, refractory to platelet transfusion 
(defined as an unsatisfactory post-transfusion platelet 
increment12). Furthermore, patients with acute leukaemia 
are particularly vulnerable to infections. Traditionally, 
the site of central venous access is guided by anatomical 
landmarks such as bony prominences, muscle surfaces, 
and arterial pulsations. This "blind" approach to the 
central veins assumes anatomical uniformity, does not 
account for the possibility of occlusions, and depends 
on correct discernment of the relationship among 
multiple anatomical landmarks. For these reasons, the 
procedure is associated with a relatively high incidence 
of complications, related to first pass failure, arterial 
punctures13 or inexperience of the operator8,9,14.
In comparison to standard CVC, US-guided CVC is 
more feasible and offers various advantages (ease of vein 
identification, a shorter duration of the procedure) which, 
together with a higher rate of success and decreased 
incidence of complications, make the latter preferable to 
the former, especially in high-risk patients4,6,15. Moreover, 
patients' compliance with this technique is high.
Table I - Patients' baseline characteristics.
Patients' characteristics With severe thrombocytopenia 
(n=39)
Without severe thrombocytopenia 
(n=392)
P value
Male/female, n. 23/16 229/163 0.9464
Age, years 53 (18-81) 50 (18-83) 0.7977
Body mass index 19 22 0.1113
Haemoglobin (g/L), median (range) 100 (50,0-130,0) 110 (70,0-160) 0.3996
White blood cell count (×109/L), median (range) 3 (0,5-50,0) 3,9(0,4-49) 0.4107
Platelet count (×109/L),median (range) 15 (10-29) 90 (65-120) 0.0001
Chemotherapy for acute haematological malignancies, n. (%) 27 (69, 2%) 272(69, 4%) 0.9838
Need for plasma exchanges, n (%) 0 (0%) 22 (5, 6%) 0.2445
Intensive therapy or transfusion requirement, n (%) 12 (30, 8%) 98 (25%) 0.5515
Table II - Success rate and complication at the time or immediately after CVC insertion.
Outcome With severe thrombocytopenia 
(n=39)
Without severe thrombocytopenia  
(n=392)
P value
Average time for the CVC, min. 4.5 4.6 0.6545
Single needle puncture rate, n (%) 39 (100%) 376 (95, 9%) 0.3813
Major complications,  n (%) 0 0 /
Minor complications, n (%) 
(haematoma and vasovagal hypotension)
1 (2, 6%)
(haematoma)
12 (3, 0%)
(7 haematoma, 5 vagal hypotension)
1.0000
Successful, n (%) 38 (97, 4%) 384 (97, 9%) 0.5777
Catheter dislocation, n (%) (2, 6%) 1 (0, 2%) 0.1730
Interrupted CVC, n (%) 0 7 (1, 7%) 0.4877
Anatomic variations, n (%) 2 (5, 1%) 8 (2, 0%) 0.2265
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Our observations confirm those from a previous 
larger study performed in cancer patients in whom this 
technique was also used in a subset of haematological 
patients with very low platelet counts, without any 
mechanical complication or major bleeding16. The 
authors did not, however, adopt any antithrombotic 
or antibiotic prophylaxis and reported some cases of 
thrombosis of the internal jugular vein and infections 
of the central venous catheters. In our study, the 
administration of antibiotics for 3 days after the 
procedure and low molecular weight heparin at 
prophylactic doses for up to 4 weeks after CVC enabled 
complete avoidance of these kinds of complications in 
all patients. 
We have shown that US-guided CVC may be 
efficacious and safe for patients with haematological 
disorders, even in urgent clinical settings. In addition, 
we highlight that the catheter was inserted into 39 
patients with very low platelet counts secondary to 
acute leukaemia and idiopathic thrombocytopenia, 
without any major complications including infections. 
Although data from other institutions might differ 
from ours, we think that the results of the present 
study are interesting because they have been 
collected from a series of vulnerable patients 
prospectively investigated over a 10-year period. 
The main limitations of this study are the absence of 
a control group and the fact that it was conducted in 
a single institution. Nevertheless, this cohort study 
was performed in a representative population and 
is especially relevant as it concerns life-threatening 
clinical conditions associated with a high risk of 
bleeding and infectious complications.
Conclusions
US-guided CVC seems to be the most suitable 
technique for catheter insertion in high-risk patients. 
In our study of haematological patients there were no 
significant differences between patients with severe 
thrombocytopenia and patients with normal to low 
platelet count in terms of success rate (97.4% vs 
97.9% respectively) and incidence of complications. 
Furthermore the administration of antibiotic and 
antithrombotic prophylaxis was effective in avoiding 
thrombosis and catheter infections in this context. In 
conclusion, US-guided CVC offers an easy, safe and 
rapid solution in high-risk haematological patients 
requiring urgent treatments.
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